Allergan plc announced that Daphne Karydas will take on the new role of Senior Vice President Corporate Financial Planning & Analysis and Strategy, and Manisha Narasimhan, will join the Company as Vice President of Investor Relations and Strategic Initiatives, effective December 10, 2018. In her new role, Ms. Karydas will continue to work with the Executive Leadership Team to develop and execute the Company's long-term financial and business strategy. Dr. Narasimhan, who joins Allergan from Regeneron Pharmaceuticals Inc., will lead the Company's engagement with the investment community. Both roles will report to Matt Walsh, Executive Vice President and Chief Financial Officer. Dr. Narasimhan joins Allergan from Regeneron, where she led the Investor Relations function. She has extensive industry experience in the biopharmaceutical sector and well-established relationships within the investment community. Previously, she was an equity research analyst at Canaccord Genuity and Piper Jaffray and has also served as a strategy consultant at Campbell Alliance. Ms. Karydas recently served as Senior Vice President Global Investor Relations and Strategy. Before that time, she was a leading institutional investor and financial analyst in the biopharmaceutical sector, joining from J.P. Morgan Asset Management.